source
- Bristol Myers details Krazati confirmatory study failure in colorectal cancerWhile Americans geared up for the July 4 holiday, Bristol Myers Squibb laid out how a confirmatory trial for its drug Krazati failed in colorectal cancer. Patients taking Krazati plus another drug,…Endpoints · 24d ago↗ source
- Roche aims to bolster breast cancer pipeline with early-stage Astex dealMonday’s deal between Otsuka’s subsidiary Astex Pharmaceuticals and Roche’s subsidiary Genentech is of interest not because it is big money — the upfront fee is just $25 million — but because of wh…Endpoints · 24d ago↗ source
- Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotPlus news about Brii Biosciences. 💰 How AbbVie got Apogee: The Chicago-area drug giant snagged Apogee Therapeutics for $10.9 billion last month after years of talking with the biotech. AbbVie held…